arrow
返回
H

Hong Wan

state university of new york (suny) system

34H指数
157论文数
4.2K被引数
收录论文 57
发表时间
Anti-cancer effect of targeting fibroblast activation protein alpha in glioblastoma through remodeling macrophage phenotype and suppressing tumor progression
err2022-11-15
err4
errOAAI
errMiao, Yazhou; Deng, Yuxuan; Liu, Jinqiu; Wang, Jing; Hu, Boyi; Hao, Shuyu; Wang, Herui; Zhang, Zhe; Jin, Zeping; Zhang, Yang; Li, Chunzhao; Zhang, Peng; Wan, Hong; Zhang, Shaodong; Feng, Jie; Ji, Nan
err分享
err收藏
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancers
err2022-01-01
err8
PREAI
errZhao, Peng; Zhuang, Linghang; Wang, Xiangzhu; Huang, Song; Wu, Heping; Zhou, Yu; Yan, Yuna; Zhang, Fan; Shen, Ru; Li, Jing; Liu, Suxing; Zhang, Rumin; Dong, Ping; Mao, Yuchang; Fan, Yuanmin; He, Chunyong; Sun, Jiakang; Zhang, Lei; Hu, Qiyue; Wan, Hong; Feng, Jun; Bai, Chang; He, Feng; Tao, Weikang
err分享
err收藏
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
err2021-04-28
err17
errOAAI
errLiu, Suxing; Liu, Dong; Shen, Ru; Li, Di; Hu, Qiyue; Yan, Yinfa; Sun, Jiakang; Zhang, Fengqi; Wan, Hong; Dong, Ping; Feng, Jun; Zhang, Rumin; Li, Jing; Zhang, Lianshan; Tao, Weikang
err分享
err收藏
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors发现羟基脒衍生物是高效,选择性的Indoleamine-2,3-双加氧酶1抑制剂
err2021-01-20
err4
errOAAI
errJin, Fangfang; Hu, Qiyue; Fei, Hongbo; Lv, Hejun; Wang, Shenglan; Gui, Bin; Zhang, Junzhen; Tu, Wangyang; Zhang, Yun; Zhang, Lei; Wan, Hong; Zhang, Limin; Hu, Bin; Yang, Fanglong; Bai, Chang; He, Feng; Zhang, Lianshan; Tao, Weikang
err分享
err收藏
err分享
err收藏
Discovery of SHR0687, a Highly Potent and Peripheral Nervous System-Restricted KOR Agonist
err2020-09-14
err8
errOAAI
errLi, Xin; Wan, Hong; Dong, Ping; Wang, Bin; Zhang, Lei; Hu, Qiyue; Zhang, Ting; Feng, Jun; He, Feng; Bai, Chang; Zhang, Lianshan; Tao, Weikang
err分享
err收藏
Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets代谢分析揭示了不同亚型垂体腺瘤的不同代谢改变,并赋予了治疗靶点
err2019-08-28
err9
errOAAI
errFeng, Jie; Gao, Hua; Zhang, Qi; Zhou, Yang; Li, Chuzhong; Zhao, Sida; Hong, Lichuan; Yang, Jinjin; Hao, Shuyu; Hong, Wan; Zhuang, Zhengping; Xu, Guowang; Zhang, Yazhuo
err分享
err收藏
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
err2019-06-08
err25
PREAI
errHao, Shuyu; Huang, Guanyou; Feng, Jie; Li, Da; Wang, Ke; Wang, Liang; Wu, Zhen; Wan, Hong; Zhang, Liwei; Zhang, Junting
err分享
err收藏
Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood-Brain Barrier Penetration
err2019-05-29
err8
errOAAI
errLi, Xin; Zhang, Zhigao; Chen, Yang; Wan, Hong; Sun, Jiakang; Wang, Bin; Feng, Bingqiang; Hu, Bing; Shi, Xingxing; Feng, Jun; Zhang, Lei; He, Feng; Bai, Chang; Zhang, Lianshan; Tao, Weikang
err分享
err收藏
Integration of Proteomics and Metabolomics Revealed Metabolite-Protein Networks in ACTH-Secreting Pituitary Adenoma
err2018-11-23
err32
errOAAI
errFeng, Jie; Zhang, Qi; Zhou, Yang; Yu, Shenyuan; Hong, Lichuan; Zhao, Sida; Yang, Jingjing; Wan, Hong; Xu, Guowang; Zhang, Yazhuo; Li, Chuzhong
err分享
err收藏